Paul Tudor Jones’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.46M | Buy |
74,896
+16,527
| +28% | +$2.18M | 0.01% | 857 |
|
|
2026
Q1 | $8.13M | Buy |
+58,369
| New | +$8.17M | 0.02% | 857 |
|
|
2025
Q4 | – | Sell |
-128,173
| Closed | -$15.6M | – | 3682 |
|
|
2025
Q3 | $14.2M | Buy |
128,173
+110,380
| +620% | +$12.5M | 0.02% | 593 |
|
|
2025
Q2 | $1.97M | Sell |
17,793
-23,936
| -57% | -$2.55M | ﹤0.01% | 1681 |
|
|
2025
Q1 | $4.68M | Sell |
41,729
-120,644
| -74% | -$12.4M | 0.02% | 816 |
|
|
2024
Q4 | $15M | Buy |
+162,373
| New | +$14.6M | 0.06% | 214 |
|
|
2024
Q3 | – | Sell |
-521,017
| Closed | -$39.8M | – | 2851 |
|
|
2024
Q2 | $35.7M | Buy |
521,017
+210,451
| +68% | +$14M | 0.18% | 71 |
|
|
2024
Q1 | $22.7M | Buy |
310,566
+273,136
| +730% | +$21M | 0.14% | 115 |
|
|
2023
Q4 | $3.03M | Buy |
+37,430
| New | +$2.91M | 0.02% | 895 |
|
|
2023
Q3 | – | Sell |
-3,874
| Closed | -$299K | – | 2491 |
|
|
2023
Q2 | $299K | Buy |
+3,874
| New | +$309K | ﹤0.01% | 2012 |
|
|
2022
Q2 | – | Sell |
-132,517
| Closed | -$7.88M | – | 2259 |
|
|
2022
Q1 | $7.88M | Buy |
132,517
+49,642
| +60% | +$3.17M | 0.18% | 102 |
|
|
2021
Q4 | $6.02M | Buy |
82,875
+77,289
| +1,384% | +$5.32M | 0.1% | 213 |
|
|
2021
Q3 | $390K | Buy |
+5,586
| New | +$392K | 0.01% | 1828 |
|
|
2021
Q2 | – | Sell |
-34,755
| Closed | -$2.25M | – | 1707 |
|
|
2021
Q1 | $2.25M | Buy |
+34,755
| New | +$2.24M | 0.05% | 469 |
|
|
2020
Q4 | – | Sell |
-25,698
| Closed | -$1.62M | – | 1427 |
|
|
2020
Q3 | $1.62M | Buy |
+25,698
| New | +$1.78M | 0.07% | 370 |
|
|
2020
Q2 | – | Sell |
-10,978
| Closed | -$821K | – | 1256 |
|
|
2020
Q1 | $821K | Sell |
10,978
-61,957
| -85% | -$4.28M | 0.07% | 309 |
|
|
2019
Q4 | $4.74M | Buy |
72,935
+28,123
| +63% | +$1.83M | 0.21% | 86 |
|
|
2019
Q3 | $2.84M | Sell |
44,812
-30,969
| -41% | -$2.02M | 0.1% | 230 |
|
|
2019
Q2 | $5.12M | Sell |
75,781
-45,338
| -37% | -$2.98M | 0.15% | 95 |
|
|
2019
Q1 | $7.87M | Buy |
121,119
+65,481
| +118% | +$4.35M | 0.33% | 48 |
|
|
2018
Q4 | $3.48M | Buy |
55,638
+35,364
| +174% | +$2.47M | 0.07% | 92 |
|
|
2018
Q3 | $1.56M | Sell |
20,274
-7,581
| -27% | -$573K | 0.04% | 343 |
|
|
2018
Q2 | $1.97M | Buy |
27,855
+3,764
| +16% | +$266K | 0.07% | 256 |
|
|
2018
Q1 | $1.82M | Buy |
24,091
+20,144
| +510% | +$1.6M | 0.06% | 179 |
|
|
2017
Q4 | $283K | Buy |
+3,947
| New | +$300K | 0.01% | 830 |
|
|
2017
Q2 | – | Sell |
-20,709
| Closed | -$1.41M | – | 1155 |
|
|
2017
Q1 | $1.41M | Buy |
20,709
+9,308
| +82% | +$655K | 0.04% | 263 |
|
|
2016
Q4 | $816K | Buy |
11,401
+8,601
| +307% | +$639K | 0.02% | 462 |
|
|
2016
Q3 | $222K | Sell |
2,800
-10,951
| -80% | -$890K | 0.01% | 1202 |
|
|
2016
Q2 | $1.15M | Sell |
13,751
-27,598
| -67% | -$2.45M | 0.02% | 396 |
|
|
2016
Q1 | $3.8M | Buy |
41,349
+24,735
| +149% | +$2.23M | 0.1% | 161 |
|
|
2015
Q4 | $1.68M | Buy |
16,614
+9,314
| +128% | +$969K | 0.05% | 250 |
|
|
2015
Q3 | $717K | Sell |
7,300
-3,080
| -30% | -$342K | 0.02% | 555 |
|
|
2015
Q2 | $1.22M | Buy |
10,380
+3,845
| +59% | +$420K | 0.04% | 340 |
|
|
2015
Q1 | $641K | Sell |
6,535
-102,837
| -94% | -$10.4M | 0.02% | 596 |
|
|
2014
Q4 | $10.3M | Buy |
109,372
+79,127
| +262% | +$8.18M | 0.36% | 37 |
|
|
2014
Q3 | $3.22M | Buy |
30,245
+20,941
| +225% | +$2.05M | 0.12% | 96 |
|
|
2014
Q2 | $771K | Sell |
9,304
-1,501
| -14% | -$117K | 0.03% | 308 |
|
|
2014
Q1 | $766K | Buy |
10,805
+2,808
| +35% | +$220K | 0.03% | 300 |
|
|
2013
Q4 | $601K | Buy |
+7,997
| New | +$557K | 0.03% | 438 |
|
|
2013
Q3 | – | Sell |
-9,200
| Closed | -$472K | – | 861 |
|
|
2013
Q2 | $472K | Buy |
+9,200
| New | +$480K | 0.04% | 360 |
|
Other funds holding GILD
Paul Tudor Jones's GILD Position: Q2 2026 in Review
Paul Tudor Jones increased its Gilead Sciences (GILD) stake by 28% in Q2 2026, buying an estimated $2.18M and bringing the position to 74,896 shares worth $9.46M. The position accounts for 0.01% of the portfolio, ranked #857.
Paul Tudor Jones first reported a position in GILD in Q2 2013 and has held it in 40 quarters since. The position peaked at $35.7M in Q2 2024. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Paul Tudor Jones held 74,896 shares of Gilead Sciences worth $9.46M as of Q2 2026.
- Paul Tudor Jones bought 16,527 Gilead Sciences shares in Q2 2026, an estimated $2.18M.
- Gilead Sciences made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #857 holding.
- Paul Tudor Jones first reported a position in Gilead Sciences in Q2 2013 and has held it in 40 quarters since.
- Paul Tudor Jones's Gilead Sciences position peaked at $35.7M in Q2 2024.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.